Search by Drug Name or NDC

    NDC 00113-0656-40 Good Sense Daytime 325; 10; 5 mg/15mL; mg/15mL; mg/15mL Details

    Good Sense Daytime 325; 10; 5 mg/15mL; mg/15mL; mg/15mL

    Good Sense Daytime is a ORAL SOLUTION in the HUMAN OTC DRUG category. It is labeled and distributed by L. Perrigo Company. The primary component is ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE.

    Product Information

    NDC 00113-0656
    Product ID 0113-0656_202a8237-76aa-4649-b199-da62997ef4f3
    Associated GPIs 43996903400910
    GCN Sequence Number 061337
    GCN Sequence Number Description d-methorphan/PE/acetaminophen LIQUID 5-325MG/15 ORAL
    HIC3 B4M
    HIC3 Description NON-OPIOID ANTITUSSIVE-DECONGESTANT-ANALGESIC COMB
    GCN 97129
    HICL Sequence Number 008885
    HICL Sequence Number Description DEXTROMETHORPHAN HBR/PHENYLEPHRINE HCL/ACETAMINOPHEN
    Brand/Generic Generic
    Proprietary Name Good Sense Daytime
    Proprietary Name Suffix non drowsy cold and flu
    Non-Proprietary Name acetaminophen, dextromethorphan Hbr, Phenylephrine HCl
    Product Type HUMAN OTC DRUG
    Dosage Form SOLUTION
    Route ORAL
    Active Ingredient Strength 325; 10; 5
    Active Ingredient Units mg/15mL; mg/15mL; mg/15mL
    Substance Name ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE
    Labeler Name L. Perrigo Company
    Pharmaceutical Class Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]
    DEA Schedule n/a
    Marketing Category OTC MONOGRAPH FINAL
    Application Number part341
    Listing Certified Through 2024-12-31

    Package

    NDC 00113-0656-40 (00113065640)

    NDC Package Code 0113-0656-40
    Billing NDC 00113065640
    Package 354 mL in 1 BOTTLE (0113-0656-40)
    Marketing Start Date 2013-01-02
    NDC Exclude Flag N
    Pricing Information N/A

    Standard Product Labeling (SPL)/Prescribing Information SPL 0122cd34-5817-4af5-a51a-8d176dee0a30 Details

    Revised: 9/2022